Company / Return on Equity (ROE)
P3 Health Partners Inc. Return on Equity (ROE) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-95.6%
FY2024
5-year range
-4614.4% / -14.8%
FY2021-FY2024
Trend
+97.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
P3 Health Partners Inc. reports negative total equity of -95.6% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-95.6% in FY2024 with a 3-year CAGR of -80.8%.
Declined from -51.6% to -95.6% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -80.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on equity (roe) increased 97.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -95.6% | +97.9% |
| FY2023 | -4614.4% | -8839.2% |
| FY2022 | -51.6% | -248.8% |
| FY2021 | -14.8% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026